Abnormally activated FGFR signaling in cancer activates a series of signaling pathways, such as PI3K-AKT-mTOR, Ras-Raf-Erk, and JAK-STAT, which results in uncontrolled cell proliferation, metastasis, and avoidance of cell death (Gschwind et al., 2004). Here, AKT1 is linked to cancer.